Connection

Elizabeth Hill to Carcinoma, Non-Small-Cell Lung

Back to Details
This is a "connection" page, showing publications Elizabeth Hill has written about Carcinoma, Non-Small-Cell Lung.
Elizabeth Hill
Connection Strength
0.121
Carcinoma, Non-Small-Cell Lung
  1. ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial. Lancet Oncol. 2018 05; 19(5):694-704.
    View in: PubMed
    Score: 0.121
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.